Efforts to develop new, more sensitive screening tests are thus likely to do more harm than good, as they increase the rate of over-diagnosis, without improving outcomes among women with aggressive cancers. What breast-cancer patients really need are tests that identify the risk that the disease actually poses, as well as new, lifesaving treatments.